Ontology highlight
ABSTRACT:
SUBMITTER: Bhatia A
PROVIDER: S-EPMC4916949 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Bhatia Ayesha A O'Brien Kathryn K Chen Mei M Wong Alex A Garner Warren W Woodley David T DT Li Wei W
Molecular therapy. Methods & clinical development 20160622
Burn injuries are a leading cause of morbidity including prolonged hospitalization, disfigurement, and disability. Currently there is no Food and Drug Administration-approved burn therapeutics. A clinical distinction of burn injuries from other acute wounds is the event of the so-called secondary burn wound progression within the first week of the injury, in which a burn expands horizontally and vertically from its initial boundary to a larger area. Therefore, an effective therapeutics for burns ...[more]